Actionnariat et activité des initiés pour Dianthus Therapeutics, Inc. (DNTH): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $102.49 |
| Capitalisation | $5.7B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-01 | Randhawa Simrat | M-Exempt | 9,375 | $207K |
| 2026-09-01 | Randhawa Simrat | M-Exempt | 7,500 | $134K |
| 2026-09-01 | Randhawa Simrat | M-Exempt | 6,249 | $136K |
| 2026-09-01 | Randhawa Simrat | M-Exempt | 9,375 | $207K |
| 2026-09-01 | Randhawa Simrat | S-Sale | 2,600 | $273K |
| 2026-09-01 | Randhawa Simrat | M-Exempt | 6,249 | $136K |
| 2026-09-01 | Randhawa Simrat | S-Sale | 7,215 | $767K |
| 2026-09-01 | Randhawa Simrat | M-Exempt | 7,500 | $134K |
| 2026-09-01 | Randhawa Simrat | S-Sale | 13,309 | $1.4M |
| 2026-08-19 | Read Simon | M-Exempt | 2,778 | $51K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $4.5M | $51.6M | $58.3M | $65.1M | $58.2M | $131.7M | $15.4M | $132.3M | $22.8M | $51.1M |
| Placements à Court Terme | 0 | 0 | $84.2M | $80.7M | $90.7M | $45.3M | $60.1M | $41.4M | $252.4M | $353.2M |
| Créances | $6.2M | 0 | 0 | 0 | 0 | 0 | $5.6M | $478000 | $807000 | $102000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $10.8M | $52.5M | $145.3M | $149.8M | $151.5M | $180.7M | $82.0M | $177.5M | $280.9M | $409.4M |
| Immobilisations Corporelles | $508000 | $1.7M | $3.1M | $9.9M | $8.3M | $7.5M | $956000 | $800000 | $1.7M | $1.6M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $11.3M | $54.5M | $157.3M | $161.5M | $161.6M | $189.9M | $83.1M | $179.4M | $374.0M | $530.9M |
| Dettes Fournisseurs | $1.7M | $167000 | $3.5M | $2.8M | $3.8M | $3.0M | $1.2M | $2.6M | $4.6M | $9.7M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.3M | $4.1M | $10.4M | $14.1M | $11.4M | $10.9M | $8.2M | $9.6M | $18.5M | $30.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.0M |
| Passifs Totaux | $2.3M | $4.1M | $11.7M | $20.3M | $17.7M | $17.3M | $9.5M | $10.5M | $21.5M | $37.5M |
| Réserves | -$9.7M | -$45.2M | -$102.7M | -$179.5M | -$254.4M | -$325.6M | -$45.9M | -$89.4M | -$174.4M | -$336.7M |
| Capitaux Propres | $9.0M | $50.3M | $145.6M | $141.2M | $143.9M | $172.7M | $73.7M | $168.9M | $352.5M | $493.4M |
| Dette Totale | 0 | 0 | 0 | 0 | 0 | 0 | $788000 | $585000 | $1.5M | $1.4M |
| Dette Nette | -$4.5M | -$51.6M | -$142.6M | -$145.7M | -$148.8M | -$176.9M | -$74.7M | -$173.1M | -$273.8M | -$402.9M |
| Fonds de Roulement | $8.5M | $48.4M | $134.9M | $135.7M | $140.1M | $169.8M | $73.8M | $167.8M | $262.5M | $378.7M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 26.10 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 23.77 |
Rentabilité
| Rentabilité des capitaux propres | -32.90% |
| Rentabilité du capital investi | -35.55% |
| Rentabilité des actifs | -30.58% |
| Marge brute | 96.01% |
| Marge opérationnelle | -11441.39% |
| Marge nette | -1570.85% |
Entreprises liées: ANAB · ATAI · BBOT · ELVN · IMTX · NKTR · OCS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DNTH: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions